title: [Perioperative chemotherapy in gastric cancer treatment - the surgeons view].
abstract: Contemporary European gastric cancer treatment guidelines recommend a short course of perioperative chemotherapy. This is supported by several randomized studies in which patients with perioperative chemotherapy had longer overall survival and better results in other parameters too (progression free survival, time to progression). The analysis of surgical therapy is given in this article. According to published data, in some patients extend of the surgery did not fulfill the requirements of contemporary surgical standards of care.
authors.forename: David
authors.initials: D
authors.lastname: Hoskovec
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018450:Disease Progression; D018572:Disease-Free Survival; D005743:Gastrectomy; D019983:Guideline Adherence; D006801:Humans; D008197:Lymph Node Excision; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*